In a move that signals a deepening commitment to international health security and collaborative governance, the World Health Organization (WHO) and the Swiss Confederation have officially renewed their Country Cooperation Strategy (CCS) for the 2024–2028 period. This formal agreement, signed on March 4, 2025, at the WHO Regional Office for Europe in Copenhagen, Denmark, marks a pivotal milestone in the relationship between a leading global health organization and a nation that serves as the diplomatic heart of the international health community.
The renewal of this partnership is not merely a bureaucratic formality; it represents a strategic alignment of priorities in an era defined by rapid epidemiological shifts, the need for robust pandemic preparedness, and the ongoing challenge of achieving Universal Health Coverage (UHC).
The Main Facts: A Partnership of Global Significance
The WHO-Switzerland Cooperation Strategy is a multi-year framework designed to harmonize the health priorities of the Swiss government with the global technical expertise and policy mandates of the WHO.
At its core, the 2024–2028 strategy focuses on three primary pillars:
- Health Security and Pandemic Preparedness: Leveraging Switzerland’s unique position as a hub for research and international diplomacy to bolster global health surveillance and response systems.
- Health System Strengthening: Promoting digital health transformation and the resilience of primary care, drawing on Switzerland’s highly sophisticated national health infrastructure.
- Global Health Governance: Ensuring that international health policy is data-driven, equitable, and capable of addressing the socioeconomic determinants of health.
By formalizing this collaboration, both parties aim to bridge the gap between high-level diplomatic discourse in Geneva and the practical, on-the-ground implementation of health initiatives across the European Region and beyond.
A Chronological Perspective: From Pilot Program to Strategic Pillar
The trajectory of the WHO-Switzerland relationship provides a blueprint for how international organizations can effectively engage with high-income nations.
2013: The Pioneering Pilot
In 2013, Switzerland broke new ground by becoming the first high-income country in the WHO European Region to pilot a formal Country Cooperation Strategy. Prior to this, CCS frameworks were primarily utilized by the WHO to provide technical support to developing nations. Switzerland’s decision to adopt this model was a radical shift, signaling that even countries with advanced health systems benefit from a structured, collaborative relationship with the WHO to address complex, cross-border health challenges.
2014–2021: Building Momentum
Throughout this period, the partnership focused on refining the model of cooperation. Switzerland integrated its national health priorities—such as combating non-communicable diseases (NCDs) and improving mental health services—into the WHO’s European Programme of Work. This period saw the strengthening of the Swiss-WHO liaison office and the establishment of regularized policy dialogues.
2022: The Mandate for Renewal
Recognizing that the post-pandemic landscape required a more agile and forward-looking framework, the WHO and Switzerland initiated the formal review process in 2022. This phase involved extensive consultations between the Swiss Federal Office of Public Health (FOPH) and WHO technical departments to ensure the new strategy would be responsive to the "new normal" of global health.
2025: Formalization and Future-Proofing
The signing ceremony on March 4, 2025, served as the culmination of these efforts. Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, and Barbara Schedler, Ambassador for Global Health at the Swiss Federal Office of Public Health, formally committed their institutions to the goals outlined in the 2024–2028 document, setting a clear path for the next four years of cooperation.
Supporting Data and Collaborative Initiatives: The BioHub System
One of the most concrete manifestations of the WHO-Switzerland partnership is the development of the WHO BioHub System. Launched to address the critical need for rapid sharing of pathogens and biological materials, the BioHub serves as a facility for the secure, safe, and rapid exchange of biological samples.
Switzerland’s role in this initiative has been foundational. By providing the physical and regulatory infrastructure required for the BioHub, Switzerland has positioned itself as a guardian of global health security. This initiative, which has been closely integrated into the broader cooperation strategy, exemplifies the "value-add" of the partnership: the WHO provides the global reach and technical standards, while Switzerland provides the operational capacity and diplomatic environment necessary for implementation.
The BioHub system is currently being scaled to incorporate AI-driven surveillance and enhanced data-sharing protocols, which will be a primary focus of the 2024–2028 period.
Official Responses: A Shared Vision for 2028
The signing ceremony highlighted the depth of the mutual trust between the two entities.
Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, noted during the proceedings:
"Switzerland’s commitment to global health goes far beyond its borders. By renewing this cooperation strategy, we are not just continuing a partnership; we are signaling to the world that even the most advanced health systems recognize the necessity of multilateralism. Switzerland is a cornerstone of our efforts to ensure health equity across the European Region."
Ambassador Barbara Schedler, speaking on behalf of the Swiss Federal Office of Public Health, added:
"The 2024–2028 strategy reflects our national ambition to contribute to a world where health is treated as a fundamental human right. By working hand-in-hand with the WHO, we are ensuring that our domestic health policies are informed by global best practices, and conversely, that the global health agenda benefits from the innovative research and clinical excellence found in Switzerland."
Implications: What This Means for the Future of Global Health
The renewal of this strategy carries significant implications for the international community.
1. Strengthening the Multilateral Order
In a climate where international institutions face increasing skepticism, the robust, long-term cooperation between a key donor nation like Switzerland and the WHO serves as a vital endorsement of the multilateral system. It demonstrates that the WHO remains a relevant, essential partner for states seeking to navigate the intricacies of global health crises.
2. A Model for High-Income Countries
The success of the Swiss CCS model provides a template for other high-income nations. As health issues become increasingly global—whether through pandemics, climate change, or the international migration of health professionals—the WHO’s expertise is becoming as relevant to wealthy nations as it is to the Global South. Switzerland’s ongoing participation encourages other nations to adopt similar strategic frameworks.
3. Focus on Innovation and Digital Health
The 2024–2028 mandate emphasizes "future-ready" health systems. This includes a heavy focus on digital health, the ethical use of artificial intelligence in diagnostics, and the development of sustainable financing models for healthcare. By embedding these objectives into the WHO-Switzerland strategy, the partners are essentially creating a pilot program for the future of 21st-century healthcare.
4. Addressing Global Health Equity
Despite Switzerland’s own health wealth, the strategy explicitly includes components aimed at addressing health inequalities. Through knowledge sharing and capacity building, the partnership seeks to export the lessons learned from the Swiss model to countries with less developed health infrastructure, thereby contributing to the WHO’s broader mission of "Health for All."
Conclusion: A Blueprint for the Next Four Years
As the world looks toward 2028, the WHO-Switzerland partnership stands as a beacon of institutional stability. The 2024–2028 Cooperation Strategy is more than a document; it is a declaration of intent. It acknowledges that in the face of increasingly complex health threats, isolationism is a luxury that no nation can afford.
By formalizing their cooperation, the WHO and Switzerland have ensured that their collaborative efforts remain focused, transparent, and aligned with the urgent needs of the global population. Whether through the technical rigor of the BioHub system or the diplomatic influence of Geneva-based initiatives, this partnership will undoubtedly remain at the center of the global effort to secure a healthier, more resilient future for all.
For those interested in the granular details of this collaboration, the full text of the WHO–Switzerland Country Cooperation Strategy 2024–2028 is available through the WHO/Europe official portal, serving as a roadmap for stakeholders, researchers, and policymakers committed to the advancement of international health.
About the Author
